You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Antimicrobial Resistance (AMR)

Test Information
Home / Tests / Critical Infectious Diseases / Xpert Xpress SARS-CoV-2/Flu/RSV

Xpert® Xpress SARS-CoV-2/Flu/RSV

Actionable rapid respiratory results to meet the challenges of the ongoing pandemic.

Xpert<sup>®&nbsp;</sup>Xpress SARS-CoV-2/Flu/RSV

The Need

  • Detection and differentiation of flu, RSV, and COVID-19 which all present with similar symptoms
  • Insights for effective triage and patient management
  • Risk assessment for patients and staff while resuming traditional healthcare procedures
  • Identify potential cases of co-infections during respiratory season
  • Current flu and SARS-CoV-2 therapies need definitive diagnosis for each pathogen

The Solution

  • Actionable detection of SARS-CoV-2, Flu A, Flu B, and RSV in as little as 25 minutes^
  • Accurate on-demand results with 1 sample collection
  • Optimizes GeneXpert® System module capacity by combining 2 Xpress tests into 1
  • Standardization of results between the central lab and near patient testing sites

The Impact

  • Empower patients with rapid results to help keep their loved ones and the community safe
  • Assist hospitals to effectively manage limited resources
  • Provide labs with single-test confidence to accelerate workflows
  • Support clinicians with on-demand, timely, and accurate results

*For Use Under an Emergency Use Authorization (EUA) only. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

^ For positives when running SARS-CoV-2 only on Xpress SARS-CoV-2/Flu/RSV; otherwise, the test will have a runtime of approximately 36 minutes.

Frequently Asked Questions

What are my options for Viral Transport Media for Xpert Xpress SARS-CoV-2/FLU/RSV

What are the requirements for verification and what guidelines do you have for transitioning from my current Xpert Xpress SARS-CoV-2 and/or Xpert Xpress Flu/RSV tests to the Xpert Xpress

What external quality control (QC) material options are available for SARS CoV-2/FLU/RSV?

What sample types and collection devices can be used with Xpert® Xpress SARS CoV-2-FLU-RSV?

Back to Top